Table 3.
Group | Basal | ATP linked | Proton leak | Maximal | Reserve | Non-mitochondrial |
---|---|---|---|---|---|---|
Healthy controls (N = 18) | 2.53 ± 0.17 | 2.01 ± 0.15 | 0.55 ± 0.05 | 6.39 ± 0.59 | 3.83 ± 0.50 | 1.32 ± 0.08 |
All porphyria (N = 22) | 2.19 ± 0.24 | 1.60 ± 0.17 | 0.38 ± 0.06 | 4.94 ± 0.91 | 3.26 ± 0.64 | 1.34 ± 0.39 |
Porphyria cutanea tarda (N = 12) | 2.04 ± 0.36 | 1.44 ± 0.25 | 0.43 ± 0.08 | 4.52 ± 1.19 | 2.89 ± 0.86 | 1.19 ± 0.26 |
Acute hepatic porphyria (N = 7) | 2.05 ± 0.18 | 1.79 ± 0.21 | 0.25 ± 0.007 | 5.28 ± 0.39 | 3.22 ± 0.52 | 0.64 ± 0.02 |
Active porphyria (N = 8) | 1.92 ± 0.47 | 1.66 ± 0.43 | 0.26 ± 0.08 | 4.44 ± 1.38 | 2.54 ± 1.00 | 0.60 ± 0.55 |
Student's t-Test P* | 0.19 | 0.015 | 0.14 | 0.06 | 0.25 | 0.90 |
Student's t-Test P** | 0.39 | 0.014 | 0.025 | 0.0002 | 0.009 | 0.34 |
Wilcoxon Rank Sum P* | 0.15 | 0.013 | 0.09 | 0.018 | 0.06 | 0.035 |
Wilcoxon Rank Sum P** | 0.25 | 0.015 | 0.018 | 0.002 | 0.012 | 0.27 |
*Healthy controls vs. all porphyria and **Healthy controls vs. active porphyria.